Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-04

Clinical Trial Update: NAC for Head Trauma-induced Anosmia [Phase 3]

View source ↗

Summary

Phase 3 trial of NAC for anosmia due to head trauma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAC

Snippet

Sponsor: University of Miami | Conditions: Anosmia, Head Trauma | Phase 3 | Status: TERMINATED | Results posted: 2021-02-04